In Vitro Study: Exploring a NOVOS Core–Based Formulation and Cellular Stress

The study, conducted at the Salk Institute for Biological Studies, examined preparations based on the NOVOS Core formulation in cell-culture models of oxytosis/ferroptosis and inflammatory signaling, processes commonly investigated in aging research.

For a more technical version of this article, click here.

All NOVOS-related findings described in this article were generated in vitro using cellular models and are intended for research purposes only. These results do not establish effects in humans or relevance to health or disease outcomes.

Introduction to Ferroptosis

Ferroptosis is a form of regulated cell death characterized by iron-dependent lipid peroxidation. Researchers use laboratory models to investigate the cellular mechanisms involved, including changes in antioxidant defenses and oxidative stress (Li et al., 2020; Xie et al., 2016; Stockwell et al., 2017).

(Note: In vitro findings described in this article reflect observations in cellular systems only. Such results are exploratory and do not establish effects in humans or relevance to health or disease outcomes. No claims are made regarding diagnosis, prevention, treatment, or mitigation of any disease. This content is provided for scientific and educational purposes only.)

Introduction to Oxytosis

Oxytosis is a form of regulated cell death first described over 30 years ago in neuronal cell models. It involves oxidative stress and shares several cellular features with ferroptosis.

Researchers study these overlapping mechanisms in laboratory models to better understand cellular stress responses and cell survival.

NOVOS Core Oxytosis/Ferroptosis Study Approach and Results

Scientists utilized two mixtures based on the NOVOS Core formulation: a water-soluble mix and a non-water soluble mix prepared in dimethyl sulfoxide (DMSO), containing fisetin and pterostilbene. These mixtures were tested separately and in combination to examine cell survival under experimentally induced oxytosis/ferroptosis-like stress in HT22 mouse hippocampal neuronal cells and nitric oxide production in LPS-stimulated BV2 microglial cells. This dual approach was used to observe how the formulation influences cellular stress responses and inflammatory signaling pathways that are widely studied in aging-related research models.

Table 1 summarizes how the tested NOVOS Core–based preparations influenced survival in HT22 mouse hippocampal neuronal cells exposed to glutamate, erastin, and RSL3. These agents are used to investigate oxytosis/ferroptosis-related cell death under controlled laboratory conditions.

The results are reported as EC50 values, which describe the amount or concentration needed to achieve the response defined for the assay. The combined mixture had lower reported EC50 values than the separate water-soluble and DMSO-soluble mixtures across the tested stressors.

These findings allow comparisons within the experimental model, provided that preparation concentrations and units are comparable. They do not, by themselves, establish synergy between ingredients or an effective dose in humans.

Nitric Oxide Measurements in BV2 Cells

Table 2 reports effects on nitric oxide (NO) production in BV2 microglial cells treated with lipopolysaccharide (LPS), a laboratory model used to study inflammatory signaling.

The reported EC50 values were 3.2 μl per 10^5 cells for the combined mixture and 2.4 μl per 10^5 cells for the DMSO-soluble mixture. These values should be interpreted alongside the preparation concentrations, assay methods, and cell-viability controls.

This laboratory readout does not establish that taking NOVOS Core reduces inflammation in people.

Commentary on the Study’s Results

Comparing the Preparations

In the HT22 cell-survival experiments, the combined mixture had lower reported EC50 values than the separate water-soluble and DMSO-soluble mixtures across the tested stressors. This pattern did not extend to the nitric oxide assay, where the DMSO-soluble mixture had the lower reported EC50.

Ferroptosis involves several interacting cellular processes, including iron handling, antioxidant defenses, and lipid peroxidation (Li et al., 2020; Xie et al., 2016). This complexity provides a rationale for investigating multi-component preparations, although the present experiments do not establish which mechanisms account for the differences observed between mixtures.

The results should therefore be interpreted separately for each assay. Establishing synergy would require an analysis of whether the combined effect exceeds the effect expected from the components.

Interpreting the Nitric Oxide Results

The formulation reduced nitric oxide production in LPS-stimulated microglial cells under the tested laboratory conditions. This observation requires interpretation alongside cell-viability controls and does not establish an effect on brain inflammation or other human outcomes.

What EC50 Values Can Tell Us

The lower reported EC50 values for the combined NOVOS Core–based formulation across the tested inducers (glutamate, erastin, and RSL3) indicate differences in the measured cell-survival responses between preparations under these laboratory conditions. These comparisons depend on the preparation concentrations and assay definitions and do not establish effective doses in humans.

Inflammation-related signaling is commonly investigated in aging research. The observed reduction in LPS-induced nitric oxide (NO) production in microglial cells provides a basis for further mechanistic research in cellular models. The nitric oxide assay also helps researchers compare the responses to different preparations: the DMSO-soluble mixture had a lower reported EC50 than the combined mixture. These observations concern a specific laboratory readout and should not be interpreted as evidence of reduced brain inflammation in humans.

Together, the experiments provide information about how water-soluble and DMSO-soluble preparations, tested separately and in combination, influenced cellular stress responses and inflammatory signaling. They support further investigation of multi-component formulations, but do not, by themselves, establish synergy between ingredients or benefits in people taking NOVOS Core.

Contextualizing the Findings in Aging and Aging Research

This study conducted on NOVOS Core by the Salk Institute’s neuroscientist, Dr. Pamela Maher, provides mechanistic evidence of how the formulation interacts with cellular processes commonly studied in aging-related research.

Addressing the Complexity of Aging

Aging is a multifactorial process involving changes in physiological function and the ability of cells to maintain homeostasis and respond to stress. Oxidative damage and chronic inflammation, often described as “inflammaging,” are among the processes investigated in aging biology (Franceschi and Campisi, 2014).

The cell-survival and nitric oxide assays examined laboratory responses related to these areas of research. They provide mechanistic observations, but do not establish that taking NOVOS Core preserves neuronal function or delays age-related cognitive decline.

Investigating Multi-Component Formulations

Aging research explores how multiple biological processes interact and whether interventions can influence more than one of these processes (Kennedy et al., 2014). Testing water-soluble and DMSO-soluble preparations separately and in combination can help researchers investigate differences in cellular responses.

In this study, the results varied between assays. Further work would be needed to identify the contributions of individual ingredients and determine whether any interactions between them are additive, synergistic, or otherwise.

Conclusion

This in vitro study examined how preparations based on the NOVOS Core formulation influenced cell survival under experimentally induced stress and nitric oxide production in a separate cellular assay.

The findings provide a basis for further research. They do not establish benefits from taking NOVOS Core, demonstrate synergy between ingredients, or support conclusions about human dosing.